Impact of Local Therapy on Disease Progression and Survival Outcomes in Oligometastatic Epidermal Growth Factor Receptor (EGFR) Mutated Non-Small Cell Lung Cancer (NSCLC) Treated with First Line EGFR Tyrosine Kinase Inhibitors (Tkis)

Saved in:
Bibliographic Details
Published inInternational journal of radiation oncology, biology, physics Vol. 108; no. 3; p. e152
Main Authors Soon, Y.Y., Lee, C.C., Koh, W.Y., Leong, C.N., Tey, J.
Format Journal Article
LanguageEnglish
Published Elsevier Inc 01.11.2020
Online AccessGet full text

Cover

More Information
ISSN:0360-3016
1879-355X
DOI:10.1016/j.ijrobp.2020.07.1326